ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

    NEXT STORY
    Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
    PREV STORY
    Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Loxo Oncology Announces Larotrectinib Pan-TRK IHC Companion Diagnostic Collaboration with Ventana Medical Systems, Inc., a member of the Roche Group

    STAMFORD, Conn., March 20, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    BioXcel Therapeutics to Present BXCL701 Clinical Data at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting

    author_avatar
    NASDAQ Market News

    Trinity Biotech plc to Announce First Quarter Fiscal Year 2019 Financial Results

    author_avatar
    NASDAQ Market News